ID   SC5A8_HUMAN             Reviewed;         610 AA.
AC   Q8N695; Q2TB99; Q7Z2H9;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   10-MAY-2017, entry version 108.
DE   RecName: Full=Sodium-coupled monocarboxylate transporter 1;
DE   AltName: Full=Apical iodide transporter;
DE   AltName: Full=Electrogenic sodium monocarboxylate cotransporter;
DE   AltName: Full=Sodium iodide-related cotransporter;
DE   AltName: Full=Solute carrier family 5 member 8;
GN   Name=SLC5A8 {ECO:0000312|EMBL:AAP46193.1};
GN   Synonyms=AIT {ECO:0000312|EMBL:AAL88746.1},
GN   SMCT {ECO:0000303|PubMed:14966140, ECO:0000303|PubMed:15090606},
GN   SMCT1 {ECO:0000303|PubMed:16729224};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAL88746.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INHIBITION.
RC   TISSUE=Kidney {ECO:0000312|EMBL:AAL88746.1};
RX   PubMed=12107270; DOI=10.1210/jcem.87.7.8797;
RA   Rodriguez A.-M., Perron B., Lacroix L., Caillou B., Leblanc G.,
RA   Schlumberger M., Bidart J.-M., Pourcher T.;
RT   "Identification and characterization of a putative human iodide
RT   transporter located at the apical membrane of thyrocytes.";
RL   J. Clin. Endocrinol. Metab. 87:3500-3503(2002).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAP46193.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], VARIANT ILE-193, FUNCTION,
RP   INDUCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Colon {ECO:0000269|PubMed:12829793};
RX   PubMed=12829793; DOI=10.1073/pnas.1430846100;
RA   Li H., Myeroff L., Smiraglia D., Romero M.F., Pretlow T.P.,
RA   Kasturi L., Lutterbaugh J., Rerko R.M., Casey G., Issa J.-P.,
RA   Willis J., Willson J.K., Plass C., Markowitz S.D.;
RT   "SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by
RT   methylation in human colon aberrant crypt foci and cancers.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:8412-8417(2003).
RN   [3] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY,
RP   STOICHIOMETRY, AND VARIANTS ILE-193 AND VAL-251.
RC   TISSUE=Intestine {ECO:0000269|PubMed:14966140};
RX   PubMed=14966140; DOI=10.1074/jbc.C400059200;
RA   Miyauchi S., Gopal E., Fei Y.-J., Ganapathy V.;
RT   "Functional identification of SLC5A8, a tumor suppressor down-
RT   regulated in colon cancer, as a Na(+)-coupled transporter for short-
RT   chain fatty acids.";
RL   J. Biol. Chem. 279:13293-13296(2004).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY,
RP   STOICHIOMETRY, AND INHIBITION.
RC   TISSUE=Kidney cortex {ECO:0000269|PubMed:15090606};
RX   PubMed=15090606; DOI=10.1113/jphysiol.2004.063859;
RA   Coady M.J., Chang M.-H., Charron F.M., Plata C., Wallendorff B.,
RA   Sah J.F., Markowitz S.D., Romero M.F., Lapointe J.-Y.;
RT   "The human tumour suppressor gene SLC5A8 expresses a Na+-
RT   monocarboxylate cotransporter.";
RL   J. Physiol. (Lond.) 557:719-731(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6] {ECO:0000312|EMBL:EAW97649.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000312|EMBL:AAI10493.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8] {ECO:0000305}
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15001644; DOI=10.1210/jc.2003-030542;
RA   Lacroix L., Pourcher T., Magnon C., Bellon N., Talbot M.,
RA   Intaraphairot T., Caillou B., Schlumberger M., Bidart J.-M.;
RT   "Expression of the apical iodide transporter in human thyroid tissues:
RT   a comparison study with other iodide transporters.";
RL   J. Clin. Endocrinol. Metab. 89:1423-1428(2004).
RN   [9] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=15361710; DOI=10.1159/000079145;
RA   Ueno M., Toyota M., Akino K., Suzuki H., Kusano M., Satoh A., Mita H.,
RA   Sasaki Y., Nojima M., Yanagihara K., Hinoda Y., Tokino T., Imai K.;
RT   "Aberrant methylation and histone deacetylation associated with
RT   silencing of SLC5A8 in gastric cancer.";
RL   Tumor Biol. 25:134-140(2004).
RN   [10] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=15867356; DOI=10.1158/0008-5472.CAN-05-0048;
RA   Hong C., Maunakea A., Jun P., Bollen A.W., Hodgson J.G.,
RA   Goldenberg D.D., Weiss W.A., Costello J.F.;
RT   "Shared epigenetic mechanisms in human and mouse gliomas inactivate
RT   expression of the growth suppressor SLC5A8.";
RL   Cancer Res. 65:3617-3623(2005).
RN   [11] {ECO:0000305}
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=17178845; DOI=10.1158/0008-5472.CAN-06-1950;
RA   Thangaraju M., Gopal E., Martin P.M., Ananth S., Smith S.B.,
RA   Prasad P.D., Sterneck E., Ganapathy V.;
RT   "SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent
RT   inhibition of histone deacetylases.";
RL   Cancer Res. 66:11560-11564(2006).
RN   [12] {ECO:0000305}
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16805814; DOI=10.1111/j.1471-4159.2006.03878.x;
RA   Martin P.M., Gopal E., Ananth S., Zhuang L., Itagaki S., Prasad B.M.,
RA   Smith S.B., Prasad P.D., Ganapathy V.;
RT   "Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled
RT   transporter for active uptake of L-lactate and ketone bodies in the
RT   brain.";
RL   J. Neurochem. 98:279-288(2006).
RN   [13] {ECO:0000305}
RP   FUNCTION, AND INHIBITION.
RX   PubMed=16729224; DOI=10.1007/s11095-006-0023-1;
RA   Itagaki S., Gopal E., Zhuang L., Fei Y.-J., Miyauchi S., Prasad P.D.,
RA   Ganapathy V.;
RT   "Interaction of ibuprofen and other structurally related NSAIDs with
RT   the sodium-coupled monocarboxylate transporter SMCT1 (SLC5A8).";
RL   Pharm. Res. 23:1209-1216(2006).
RN   [14] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=18037591; DOI=10.1016/j.cdp.2007.09.002;
RA   Park J.Y., Zheng W., Kim D., Cheng J.Q., Kumar N., Ahmad N.,
RA   Pow-Sang J.;
RT   "Candidate tumor suppressor gene SLC5A8 is frequently down-regulated
RT   by promoter hypermethylation in prostate tumor.";
RL   Cancer Detect. Prev. 31:359-365(2007).
RN   [15] {ECO:0000305}
RP   FUNCTION, STOICHIOMETRY, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17245649; DOI=10.1007/s11095-006-9176-1;
RA   Gopal E., Miyauchi S., Martin P.M., Ananth S., Roon P., Smith S.B.,
RA   Ganapathy V.;
RT   "Transport of nicotinate and structurally related compounds by human
RT   SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian
RT   intestinal tract.";
RL   Pharm. Res. 24:575-584(2007).
CC   -!- FUNCTION: Acts as an electrogenic sodium (Na(+)) and chloride
CC       (Cl-)-dependent sodium-coupled solute transporter, including
CC       transport of monocarboxylates (short-chain fatty acids including
CC       L-lactate, D-lactate, pyruvate, acetate, propionate, valerate and
CC       butyrate), lactate, mocarboxylate drugs (nicotinate, benzoate,
CC       salicylate and 5-aminosalicylate) and ketone bodies (beta-D-
CC       hydroxybutyrate, acetoacetate and alpha-ketoisocaproate), with a
CC       Na(+):substrate stoichiometry of between 4:1 and 2:1. Catalyzes
CC       passive carrier mediated diffusion of iodide. Mediates iodide
CC       transport from the thyrocyte into the colloid lumen through the
CC       apical membrane. May be responsible for the absorption of D-
CC       lactate and monocarboxylate drugs from the intestinal tract. Acts
CC       as a tumor suppressor, suppressing colony formation in colon
CC       cancer, prostate cancer and glioma cell lines. May play a critical
CC       role in the entry of L-lactate and ketone bodies into neurons by a
CC       process driven by an electrochemical Na(+) gradient and hence
CC       contribute to the maintenance of the energy status and function of
CC       neurons. {ECO:0000269|PubMed:12107270,
CC       ECO:0000269|PubMed:12829793, ECO:0000269|PubMed:14966140,
CC       ECO:0000269|PubMed:15090606, ECO:0000269|PubMed:15361710,
CC       ECO:0000269|PubMed:15867356, ECO:0000269|PubMed:16729224,
CC       ECO:0000269|PubMed:16805814, ECO:0000269|PubMed:17178845,
CC       ECO:0000269|PubMed:17245649, ECO:0000269|PubMed:18037591}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1442 uM for beta-D-hydroxybutyate
CC         {ECO:0000269|PubMed:16805814};
CC         KM=2327 uM for beta-L-hydroxybutyate
CC         {ECO:0000269|PubMed:16805814};
CC         KM=1088 uM for D-lactate {ECO:0000269|PubMed:16805814};
CC         KM=184 uM for L-lactate {ECO:0000269|PubMed:16805814};
CC         KM=387 uM for pyruvate {ECO:0000269|PubMed:16805814};
CC         KM=213 uM for acetoacetate {ECO:0000269|PubMed:16805814};
CC         KM=209 uM for alpha-ketoisocaproate
CC         {ECO:0000269|PubMed:16805814};
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:12107270, ECO:0000269|PubMed:15001644,
CC       ECO:0000269|PubMed:17245649}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12107270, ECO:0000269|PubMed:15001644,
CC       ECO:0000269|PubMed:17245649}. Note=Expressed at the apical
CC       membrane of normal tall thyrocytes and of colonic epithelial
CC       cells. {ECO:0000269|PubMed:12107270, ECO:0000269|PubMed:15001644,
CC       ECO:0000269|PubMed:17245649}.
CC   -!- TISSUE SPECIFICITY: Expressed in normal thyroid, localized at the
CC       apical pole of thyroid cells facing the colloid lumen, but
CC       expression profoundly decreased in thyroid carcinomas. Expressed
CC       in normal colon but absent in colon aberrant crypt foci and colon
CC       cancers. Present in normal kidney cortex, brain, prostate, gastric
CC       mucosa and breast tissue but was significantly down-regulated in
CC       primary gliomas, gastric cancer, prostate tumors and breast
CC       tumors. {ECO:0000269|PubMed:12107270, ECO:0000269|PubMed:12829793,
CC       ECO:0000269|PubMed:14966140, ECO:0000269|PubMed:15001644,
CC       ECO:0000269|PubMed:15090606, ECO:0000269|PubMed:15361710,
CC       ECO:0000269|PubMed:15867356, ECO:0000269|PubMed:17178845,
CC       ECO:0000269|PubMed:17245649, ECO:0000269|PubMed:18037591}.
CC   -!- INDUCTION: Down-regulated in some primary cancers; due to aberrant
CC       methylation in primary colon cancers, astrocytomas and
CC       oligodendrogliomas as well as in cancers of the colon, prostate
CC       and gastric regions, and glial cell lines. Expression reactivated
CC       on treatment with a demethylating drug, 5-azacytidine.
CC       {ECO:0000269|PubMed:12829793, ECO:0000269|PubMed:15361710,
CC       ECO:0000269|PubMed:15867356, ECO:0000269|PubMed:18037591}.
CC   -!- MISCELLANEOUS: Increase of iodide influx inhibited by addition of
CC       perchlorate (NaClO(4)), a competitive inhibitor of iodide uptake
CC       catalyzed by sodium iodide symporter (NIS). Cotransport of
CC       monocarboxylates and nicotinate strongly inhibited by probenecid,
CC       nonsteroid anti-inflammatory drugs (ibuprofen, fenoprofen,
CC       ketprofen, naproxen) in a Na(+)-dependent manner or by prolonged
CC       exposure to external concentrations of monocarboxylates.
CC   -!- SIMILARITY: Belongs to the sodium:solute symporter (SSF)
CC       (TC 2.A.21) family. {ECO:0000255}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SLC5A8ID44089ch12q23.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY081220; AAL88746.1; -; mRNA.
DR   EMBL; AF536216; AAP46193.1; -; mRNA.
DR   EMBL; AF536217; AAP46194.1; -; Genomic_DNA.
DR   EMBL; AC079953; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97649.1; -; Genomic_DNA.
DR   EMBL; BC110492; AAI10493.1; -; mRNA.
DR   CCDS; CCDS9080.1; -.
DR   RefSeq; NP_666018.3; NM_145913.3.
DR   UniGene; Hs.444536; -.
DR   ProteinModelPortal; Q8N695; -.
DR   BioGrid; 127763; 21.
DR   IntAct; Q8N695; 1.
DR   STRING; 9606.ENSP00000445340; -.
DR   DrugBank; DB01762; Acetoacetic Acid.
DR   DrugBank; DB08872; gabapentin enacarbil.
DR   DrugBank; DB00627; Niacin.
DR   GuidetoPHARMACOLOGY; 922; -.
DR   TCDB; 2.A.21.5.3; the solute:sodium symporter (sss) family.
DR   iPTMnet; Q8N695; -.
DR   PhosphoSitePlus; Q8N695; -.
DR   BioMuta; SLC5A8; -.
DR   DMDM; 296452898; -.
DR   PaxDb; Q8N695; -.
DR   PeptideAtlas; Q8N695; -.
DR   PRIDE; Q8N695; -.
DR   Ensembl; ENST00000536262; ENSP00000445340; ENSG00000256870.
DR   Ensembl; ENST00000572861; ENSP00000461697; ENSG00000262217.
DR   GeneID; 160728; -.
DR   KEGG; hsa:160728; -.
DR   UCSC; uc001thz.5; human.
DR   CTD; 160728; -.
DR   DisGeNET; 160728; -.
DR   GeneCards; SLC5A8; -.
DR   H-InvDB; HIX0036731; -.
DR   HGNC; HGNC:19119; SLC5A8.
DR   MIM; 608044; gene.
DR   neXtProt; NX_Q8N695; -.
DR   OpenTargets; ENSG00000256870; -.
DR   PharmGKB; PA134989874; -.
DR   eggNOG; KOG2349; Eukaryota.
DR   eggNOG; COG0591; LUCA.
DR   GeneTree; ENSGT00760000118955; -.
DR   HOGENOM; HOG000261662; -.
DR   HOVERGEN; HBG057280; -.
DR   InParanoid; Q8N695; -.
DR   KO; K14388; -.
DR   OMA; DILQDFP; -.
DR   OrthoDB; EOG091G07OC; -.
DR   PhylomeDB; Q8N695; -.
DR   TreeFam; TF316728; -.
DR   Reactome; R-HSA-197264; Nicotinamide salvaging.
DR   Reactome; R-HSA-428643; Organic anion transporters.
DR   GeneWiki; SLC5A8; -.
DR   GenomeRNAi; 160728; -.
DR   PRO; PR:Q8N695; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000256870; -.
DR   CleanEx; HS_SLC5A8; -.
DR   Genevisible; Q8N695; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008028; F:monocarboxylic acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0022803; F:passive transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006811; P:ion transport; TAS:Reactome.
DR   GO; GO:0034356; P:NAD biosynthesis via nicotinamide riboside salvage pathway; TAS:Reactome.
DR   GO; GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW.
DR   InterPro; IPR001734; Na/solute_symporter.
DR   Pfam; PF00474; SSF; 1.
DR   TIGRFAMs; TIGR00813; sss; 1.
DR   PROSITE; PS50283; NA_SOLUT_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion transport; Membrane; Polymorphism; Reference proteome; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix;
KW   Transport; Tumor suppressor.
FT   CHAIN         1    610       Sodium-coupled monocarboxylate
FT                                transporter 1.
FT                                /FTId=PRO_0000334499.
FT   TOPO_DOM      1      9       Extracellular. {ECO:0000255}.
FT   TRANSMEM     10     30       Helical. {ECO:0000255}.
FT   TOPO_DOM     31     51       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     52     72       Helical. {ECO:0000255}.
FT   TOPO_DOM     73     83       Extracellular. {ECO:0000255}.
FT   TRANSMEM     84    104       Helical. {ECO:0000255}.
FT   TOPO_DOM    105    132       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    133    153       Helical. {ECO:0000255}.
FT   TOPO_DOM    154    161       Extracellular. {ECO:0000255}.
FT   TRANSMEM    162    182       Helical. {ECO:0000255}.
FT   TOPO_DOM    183    189       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    190    210       Helical. {ECO:0000255}.
FT   TOPO_DOM    211    239       Extracellular. {ECO:0000255}.
FT   TRANSMEM    240    260       Helical. {ECO:0000255}.
FT   TOPO_DOM    261    279       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    280    300       Helical. {ECO:0000255}.
FT   TOPO_DOM    301    336       Extracellular. {ECO:0000255}.
FT   TRANSMEM    337    359       Helical. {ECO:0000255}.
FT   TOPO_DOM    360    389       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    390    410       Helical. {ECO:0000255}.
FT   TOPO_DOM    411    415       Extracellular. {ECO:0000255}.
FT   TRANSMEM    416    436       Helical. {ECO:0000255}.
FT   TOPO_DOM    437    439       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    440    460       Helical. {ECO:0000255}.
FT   TOPO_DOM    461    518       Extracellular. {ECO:0000255}.
FT   TRANSMEM    519    539       Helical. {ECO:0000255}.
FT   TOPO_DOM    540    610       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    569    572       Poly-Lys. {ECO:0000255}.
FT   CARBOHYD    485    485       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     193    193       V -> I (in dbSNP:rs1709189).
FT                                {ECO:0000269|PubMed:12829793,
FT                                ECO:0000269|PubMed:14966140}.
FT                                /FTId=VAR_057336.
FT   VARIANT     251    251       F -> V (in dbSNP:rs11834933).
FT                                {ECO:0000269|PubMed:14966140}.
FT                                /FTId=VAR_057337.
FT   CONFLICT    490    490       M -> I (in Ref. 1; AAL88746 and 2;
FT                                AAP46193/AAP46194). {ECO:0000305}.
SQ   SEQUENCE   610 AA;  66578 MW;  47FF410B895DB692 CRC64;
     MDTPRGIGTF VVWDYVVFAG MLVISAAIGI YYAFAGGGQQ TSKDFLMGGR RMTAVPVALS
     LTASFMSAVT VLGTPSEVYR FGAIFSIFAF TYFFVVVISA EVFLPVFYKL GITSTYEYLE
     LRFNKCVRLC GTVLFIVQTI LYTGIVIYAP ALALNQVTGF DLWGAVVATG VVCTFYCTLG
     GLKAVIWTDV FQVGIMVAGF ASVIIQAVVM QGGISTILND AYDGGRLNFW NFNPNPLQRH
     TFWTIIIGGT FTWTSIYGVN QSQVQRYISC KSRFQAKLSL YINLVGLWAI LTCSVFCGLA
     LYSRYHDCDP WTAKKVSAPD QLMPYLVLDI LQDYPGLPGL FVACAYSGTL STVSSSINAL
     AAVTVEDLIK PYFRSLSERS LSWISQGMSV VYGALCIGMA ALASLMGALL QAALSVFGMV
     GGPLMGLFAL GILVPFANSI GALVGLMAGF AISLWVGIGA QIYPPLPERT LPLHLDIQGC
     NSTYNETNLM TTTEMPFTTS VFQIYNVQRT PLMDNWYSLS YLYFSTVGTL VTLLVGILVS
     LSTGGRKQNL DPRYILTKED FLSNFDIFKK KKHVLSYKSH PVEDGGTDNP AFNHIELNSD
     QSGKSNGTRL
//
